Reasons for Emergency CallsRenforSMURNCT06182514
What Are the Main Themes Concerned by the Second-line SMUR 67, Known as Reinforcements, in the Bas-Rhin Sector
An observational study of Reasons for Emergency Calls, run by University Hospital, Strasbourg, France at 1 site in France.
Trial summary
In this study the investigators wish to evaluate the possibility of anticipating the requests for SMUR reinforcement within the SAMU67. The studied population concerns each patient having benefited from an SMUR at the time of his pre-hospital care. Read more about this study
- Who is it for?
- Ages 1 month and older
- Conditions the study is for
- Reasons for Emergency Calls
- How many people
- 1,200 participants
- Where
- 1 siteFrance
- Study dates
- 1 Jul 2022to 30 Jun 2024
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 1 month and older
- All sexes
- Child, Adult, Older adult
Study population: Adult patients having benefited from a pre-hospital SMUR over the period from 01/01/2020 to 14/07/2020.
Who may be able to join
- Adult patients having benefited from a pre-hospital SMUR over the period from 01/01/2020 to 14/07/2020.
- No opposition from the patient or his parental authority to the re-use of his medical data for scientific research.
Who cannot join
- Presence of opposition from the patient or his parental authority to the re-use of his medical data for scientific research purposes.
Trial locations and contacts
1 site in 1 country.
France1 site, 1 recruiting
- Recruiting
Service d'Urgences Médico-Chirurgicales Adules
Strasbourg, 67091
Anne WACH-HOFFMANN, 33 3 88 12 81 79, anne.hoffmann@chru-strasbourg.fr
Anne WACH-HOFFMANN, MD
About this study
Official title: State of Play at the SAMU 67: What Are the Themes Mainly Concerned by the Second Intention SMUR, Called Reinforcements, on the Sector of the Bas-Rhin? Are There Modifiable Factors That Could Allow us to Anticipate Them Better
In this study the investigators wish to evaluate the possibility of anticipating the requests for SMUR reinforcement within the SAMU67.
The studied population concerns each patient having benefited from an SMUR at the time of his pre-hospital care. The investigators expect from this study an improvement of the assumption of responsibility of the patients in the future with optimization of the delay of sending of an SMUR when this one is necessary.
- Conditions
- Reasons for Emergency Calls
- Keywords
- emergency calls, SAMU67, SMUR
What is being measured
The primary outcome is the main question the study is designed to answer.
Retrospective description of the main reasons and themes of patient calls leading to the Emergency Medical Service being sent for reinforcement
Measured: Through study completion, an average of 12 months
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted27 Dec 2023
- Study start1 Jul 2022
- Primary completionJun 2024 (estimated)
- Study completion30 Jun 2024 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Reasons for Emergency CallsStudies of the same condition, open and under way.
- More trials run by University Hospital, Strasbourg, FranceThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Retrospective
- Enrolment
- 1,200 participants (estimated)
Sponsor and investigators
- Lead sponsor
- University Hospital, Strasbourg, France
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06182514
- Sponsor's protocol ID
- 8675
- Acronym
- RenforSMUR
- Status last verified
- Dec 2023
- First submitted
- 6 Sep 2022
- Last updated
- 27 Dec 2023
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Study at a glance
From the registry record, last updated by the sponsor on 27 Dec 2023. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- State of Play at the SAMU 67: What Are the Themes Mainly Concerned by the Second Intention SMUR, Called Reinforcements, on the Sector of the Bas-Rhin? Are There Modifiable Factors That Could Allow us to Anticipate Them Better
- ClinicalTrials.gov ID
- NCT06182514
- Acronym / sponsor ID
- RenforSMUR / 8675
- Conditions
- Reasons for Emergency Calls
- Keywords
- emergency calls, SAMU67, SMUR
- Study type
- Observational
- Recruitment status
- Unknown status
- Enrolment
- 1,200 participants (estimated)
- Lead sponsor
- University Hospital, Strasbourg, FranceUniversity, hospital or other
- Study start
- 1 Jul 2022 (actual)
- Primary completion
- Jun 2024 (estimated)
- Study completion
- 30 Jun 2024 (estimated)
- First posted
- 27 Dec 2023 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
In this study the investigators wish to evaluate the possibility of anticipating the requests for SMUR reinforcement within the SAMU67.
The studied population concerns each patient having benefited from an SMUR at the time of his pre-hospital care. The investigators expect from this study an improvement of the assumption of responsibility of the patients in the future with optimization of the delay of sending of an SMUR when this one is necessary.
Study design
- Observational model
- Cohort
- Time perspective
- Retrospective
Who may qualify
- Ages
- 1 month and older
- Sex
- All
- Age groups
- Child, Adult, Older adult
- Study population
- Adult patients having benefited from a pre-hospital SMUR over the period from 01/01/2020 to 14/07/2020.
Key inclusion criteria (2 listed)
- Adult patients having benefited from a pre-hospital SMUR over the period from 01/01/2020 to 14/07/2020.
- No opposition from the patient or his parental authority to the re-use of his medical data for scientific research.
Key exclusion criteria (1 listed)
- Presence of opposition from the patient or his parental authority to the re-use of his medical data for scientific research purposes.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
Retrospective description of the main reasons and themes of patient calls leading to the Emergency Medical Service being sent for reinforcement
Time frame: Through study completion, an average of 12 months
Results and safety
Results are not available in the source record.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 27 Dec 2023.
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Reasons for Emergency Calls, run by University Hospital, Strasbourg, France at 1 site in France.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 2 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: status not confirmed, as of the sponsor's last update on 27 Dec 2023. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
Results are not available in the source record.
How can a doctor refer a patient or contact the research team?
Contact Anne WACH-HOFFMANN, MD (33 3 88 12 81 79, anne.hoffmann@chru-strasbourg.fr), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Retrospective description of the main reasons and themes of patient calls leading to the Emergency Medical Service being sent for reinforcement (time frame: Through study completion, an average of 12 months). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 27 Dec 2023.